Innovation Pharmaceuticals Inc (IPIX)

[rule_rationale]

Regarding Brilacidin's half-life: if I am remembering correctly, B has an advantageous ability to maintain a film layer adhesion to biological surfaces, thus making it an interesting option for ophthalmic uses as one would not need an over-frequent drip dose to the eye. It was brought up at the same time this insight was highlighted that perhaps orthopedic implants ranging from screws to joint replacements might benefit from a B-layering prior to installation. However, the body's ability to remove B from the bloodstream is sufficient enough to consider the drug in the shorter half-life category as it pertains to intravenous application. Someone correct me if I remembered this wrong.